1. Home
  2. NRXP vs VRA Comparison

NRXP vs VRA Comparison

Compare NRXP & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • VRA
  • Stock Information
  • Founded
  • NRXP 2015
  • VRA 1982
  • Country
  • NRXP United States
  • VRA United States
  • Employees
  • NRXP N/A
  • VRA N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • VRA Apparel
  • Sector
  • NRXP Health Care
  • VRA Consumer Discretionary
  • Exchange
  • NRXP Nasdaq
  • VRA Nasdaq
  • Market Cap
  • NRXP 58.5M
  • VRA 60.6M
  • IPO Year
  • NRXP N/A
  • VRA 2010
  • Fundamental
  • Price
  • NRXP $3.58
  • VRA $2.05
  • Analyst Decision
  • NRXP Strong Buy
  • VRA Buy
  • Analyst Count
  • NRXP 5
  • VRA 3
  • Target Price
  • NRXP $31.40
  • VRA $4.00
  • AVG Volume (30 Days)
  • NRXP 416.8K
  • VRA 222.4K
  • Earning Date
  • NRXP 11-13-2025
  • VRA 09-11-2025
  • Dividend Yield
  • NRXP N/A
  • VRA N/A
  • EPS Growth
  • NRXP N/A
  • VRA N/A
  • EPS
  • NRXP N/A
  • VRA N/A
  • Revenue
  • NRXP N/A
  • VRA $332,526,000.00
  • Revenue This Year
  • NRXP N/A
  • VRA N/A
  • Revenue Next Year
  • NRXP $395.09
  • VRA $2.33
  • P/E Ratio
  • NRXP N/A
  • VRA N/A
  • Revenue Growth
  • NRXP N/A
  • VRA N/A
  • 52 Week Low
  • NRXP $1.10
  • VRA $1.71
  • 52 Week High
  • NRXP $6.01
  • VRA $5.99
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 67.97
  • VRA 51.62
  • Support Level
  • NRXP $3.19
  • VRA $2.08
  • Resistance Level
  • NRXP $3.84
  • VRA $2.23
  • Average True Range (ATR)
  • NRXP 0.22
  • VRA 0.10
  • MACD
  • NRXP 0.05
  • VRA 0.01
  • Stochastic Oscillator
  • NRXP 70.87
  • VRA 53.61

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: